Browse Drug Recalls
8 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 8 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 8 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 11, 2026 | Sterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoline HCl 0.02% Lu... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidon... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange s... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Sterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Sterile Eye Drops, ORIGINAL, Tetrahydrozoline HCl 0.05% Redness Reliever ¿ ... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Sterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
| Sep 11, 2026 | Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DIS... | Lack of Assurance of Sterility | Class II | K.C. Pharmaceuticals, Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.